<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220127053838N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-11</date_registration>
      <public_title>Radial extracorporeal shock wave therapy addition on routine physiotherapy treatment  on the balance&amp; pain &amp; disability of patients with chronic non-specific low back pain caused by gluteal muscle trigger points</public_title>
      <acronym></acronym>
      <scientific_title>The effect of radial extracorporeal shock wave therapy addition on routine physiotherapy treatment  on the balance&amp; pain &amp; disability of patients with chronic non-specific low back pain caused by gluteal muscle trigger points</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61597</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Single, Purpose: Treatment, Randomization description: In this study, we use the randomized permutation block method for random assignment. The procedure will be such that two and six blocks with a combination of A (intervention group) and B (control group) will be the criteria for operation.Depending on the different combinations, each of the blocks is assigned a number as follows:
Block 1: BBABAA
Block 2: BA
Block 3: BBAABA
Block 4: BABBAA
Block 5: AB
Block 6: AB
Block 7: BA
Block 8: AB
Block 9: BAAABB
Using a table of random numbers, considering the numbers 1 to 9 and deleting the number zero, the blocks are selected respectively and the method of assigning patients to one of the groups A and B is done according to the selected blocks. After preparing a randomization list for each patient, they will have a number in the order of enrollment (from 1 to 34)
A sealed envelope is provided with A or B written inside the envelope based on the compiled list. The researcher who does not know the main list, after registering the person entered to study and check the number of the person, opens the relevant envelope and realizes the type of intervention based on the contents of the envelope. In this way, the researcher realizes the type of intervention only after the patient enters the study and determines his eligibility, by opening the envelope, and finally we will have two balanced groups, Blinding description: The person doing the assessment is different from the person doing the intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic nonspecific low back pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: People in the intervention group, in addition to routine physiotherapy treatment, include 2 sessions per week for 5 weeks, a hot pack for 20 minutes, and  ultrasound with a frequency of 1 MHz for 5 minutes, and TENS a frequency of 5 Hz for 15 minutes, and a shock wave for 2 sessions. Receives weekly for 5 weeks with intensityof 3, Frequency 10 and pulse 2000 for 7 minutes. Intervention 2: Control group: Control group two days a week for 5 weeks of routine physiotherapy treatment which includes a hot pack for 20 minutes and ultrasound with a frequency of 1 MHz for 5 minutes and TENS with a frequency of 5 Hz for 15 minutes with shock wave off.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Rozita Hedayati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Semnan University of Medical Sciences and Health Services, Basij Boulevard, Semnan, Iran</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514799442</zip>
        <telephone>+98 23 3344 1022</telephone>
        <email>rosehed@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Ali Asghar Ashtiyani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Neuromuscular Rehabilitation Research Center, Next to Nemat Ice Cream, Quds Boulevard, Semnan, Iran</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9837535196</zip>
        <telephone>+98 23 3332 8502</telephone>
        <email>seyedashtiyani@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age20-50
Have experienced back pain for at least more than 3 months
The patient has an inability to function due to back pain
The patient with low back pain has no history of lumbar surgery
The patient's pain should be between 3 and 7 based on the visual pain questionnaire
The patient has pain and trigger points in the gluteal area based on Travel and Simmons pain pattern
Patient with gluteal muscle weakness on the dominant side compared to the healthy side based on manual muscle strength test (MMT)</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Symptoms of Horsetail Syndrome include: Changes in urinary and fecal control, Saddle anesthesia, General anesthesia and general numbness
Any symptoms of a serious spinal involvement include: chest pain, extensive paresthesia in the limbs, weakness in the lower limbs
Any major cognitive impairment and severe aphasia
Spinal fractures
Postural vertigo
Pregnancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: People in the intervention group, in addition to routine physiotherapy treatment, include 2 sessions per week for 5 weeks, a hot pack for 20 minutes, and  ultrasound with a frequency of 1 MHz for 5 minutes, and TENS a frequency of 5 Hz for 15 minutes, and a shock wave for 2 sessions. Receives weekly for 5 weeks with intensityof 3, Frequency 10 and pulse 2000 for 7 minutes</i_keyword>
      <i_keyword>Control group: Control group two days a week for 5 weeks of routine physiotherapy treatment which includes a hot pack for 20 minutes and ultrasound with a frequency of 1 MHz for 5 minutes and TENS with a frequency of 5 Hz for 15 minutes with shock wave off.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Static Balance. Timepoint: Sessions 1 and 10. Method of measurement: Biodex.</prim_outcome>
      <prim_outcome>Dynamic Balance. Timepoint: Sessions 1 and 10. Method of measurement: Biodex.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain. Timepoint: Sessions 1 and 10. Method of measurement: VAS.</sec_outcome>
      <sec_outcome>Disability. Timepoint: Sessions 1 and 10. Method of measurement: Rolland-Morris.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support/>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-29</approval_date>
        <contact_name>Semnan University of Medical Sciences</contact_name>
        <contact_address>Semnan University of Medical Sciences and Health Services, Basij Street, Semnan, Iran Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
